Essayer OR - Gratuit
Novo moves HC to restrain Sun Pharma
Mint Mumbai
|December 10, 2025
As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launch copies of the drug.
The Danish drugmaker on Tuesday moved the Delhi High Court, seeking to restrain domestic giant Sun Pharmaceutical Industries from launching its generic version of semaglutide, a widely prescribed drug for diabetes and weight loss.
The matter was heard briefly by a bench headed by justice Tejas Karia, who transferred the case to the bench already hearing Novo's parallel litigation against Dr. Reddy’s Laboratories and Natco Pharma concerning the same patent.
The plea is likely to be taken up today before justice Manmeet Pritam Singh Arora, who last week allowed Dr. Reddy's Laboratories to export semaglutide to non-patent nations.
Cette histoire est tirée de l'édition December 10, 2025 de Mint Mumbai.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint Mumbai
Mint Mumbai
This year’s PF payout is good news for workers
The Employees’ Provident Fund Organisation has held its interest rate unchanged at 8.25% despite policy rate cuts over the year by the Reserve Bank of India. And for good reason too
2 mins
March 04, 2026
Mint Mumbai
AI developers should shrug off intellectual property leakages
Anthropic’s complaint against three Chinese labs illustrates why
3 mins
March 04, 2026
Mint Mumbai
A ‘FIGHT ABOUT VIBES’ DROVE THE PENTAGON’S BREAKUP WITH ANTHROPIC
The AI giant’s CEO Amodei and Defense Secretary Hegseth have contrasting personalities and worldviews. They proved difficult to reconcile
9 mins
March 04, 2026
Mint Mumbai
Japan in talks with India for Rajasthan rare earth mining
Japan is in talks with India to jointly explore rare earth deposits in the desert state of Rajasthan, two people familiar with the discussions said, as Tokyo seeks to reduce reliance on China for supplies critical to magnet manufacturing.
1 mins
March 04, 2026
Mint Mumbai
U.S. success against Iran could be a game changer for world oil security
Here are countless ways the U.S. and Israeli attack on Iran could go wrong.
3 mins
March 04, 2026
Mint Mumbai
War meets peak OMC earnings
The market’s reaction to the joint US-Israel strikes on Tran wasn’t exactly subtle.
2 mins
March 04, 2026
Mint Mumbai
Allu Arjun row: going viral comes at a cost for celebrities
The controversy involving actor Allu Arjun taking legal action against a brand strategist over remarks made on a podcast has highlighted a growing challenge for celebs: reputational risk in the age of short-form videos, and Al-generated content.
2 mins
March 04, 2026
Mint Mumbai
US-Iran war puts tourism stocks under pressure
The US-Iran war could weigh on tourism-related stocks, as rising crude oil prices push up operating costs and security concerns dampen travel.
1 mins
March 04, 2026
Mint Mumbai
Cargo agents seek relief as war grounds shipments at airports
India's air cargo agents have urged the government to step in and provide relief to exporters hit by flight disruptions caused by the escalating war between Iran and the US, which has led to widespread airspace closures across parts of West Asia.
1 mins
March 04, 2026
Mint Mumbai
AIF reset: greater flexibility, more risk for retail investors
New norms expand private-market access but deepen concentration and liquidity trade-offs
3 mins
March 04, 2026
Listen
Translate
Change font size